Viroclinics Biosciences specialises in virology testing services. The company performs laboratory tests to determine the safety and efficacy of new medicines or medicines that come onto the market in an adapted form. Its customers are major pharmaceutical development companies, manufacturers, and contract organisations that develop anti-viral drugs and vaccines. Parcom’s involvement facilitated the broadening of their portfolio from respiratory viruses to other viral targets.